Results 131 to 140 of about 25,109 (253)

Zebrafish her3 knockout impacts developmental and cancer-related gene signatures.

Developmental Biology, 2023
Matthew R. Kent, Delia Calderon, Katherine M. Silvius, Jack Kucinski, Collette A. LaVigne, Matthew V. Cannon, Genevieve C. Kendall   +6 more
semanticscholar   +1 more source

Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer

, 2020
J. J. Tao, P. Castel, N. Radosevic-Robin, M. Elkabets, N. Auricchio, N. Aceto, G. Weitsman, P. Barber, B. Vojnovic, H. Ellis, N. Morse, N. T. Viola-Villegas, A. Bosch, D. Juric, S. Hazra, S. Singh, P. Kim, A. Bergamaschi, S. Maheswaran, T. Ng, F. Penault-Llorca, J. S. Lewis, L. A. Carey, C. M. Perou, J. Baselga, M. Scaltriti   +25 more
openalex   +1 more source

Supplementary Material and Methods from Targeting of PYK2 Synergizes with EGFR Antagonists in Basal-like TNBC and Circumvents HER3-Associated Resistance via the NEDD4–NDRG1 Axis

, 2023
Nandini Verma, Anna‐Katharina Müller, Charu Kothari, Effrosini Panayotopoulou, Amir Kedan, Michael Selitrennik, Gordon B. Mills, Lan K. Nguyen, Sung‐Young Shin, Thomas Karn, Uwe Holtrich, Sima Lev   +11 more
openalex   +1 more source

Structures of the HER2–HER3–NRG1β complex reveal a dynamic dimer interface

Nature, 2021
D. Diwanji, R. Trenker, T. Thaker, Feng Wang, D. Agard, K. Verba, N. Jura   +6 more
semanticscholar   +1 more source

Supplementary Table 2 from Antiproliferative Effect of Lapatinib in HER2-Positive and HER2-Negative/HER3-High Breast Cancer: Results of the Presurgical Randomized MAPLE Trial (CRUK E/06/039)

, 2023
Alexandra Léary, Abigail Evans, Stephen Johnston, Roger A’Hern, Judith M. Bliss, Rashmita Sahoo, Simone Detre, Benjamin P. Haynes, Margaret Hills, Catherine Harper‐Wynne, Nigel Bundred, Gill Coombes, Ian Smith, Mitch Dowsett   +13 more
openalex   +1 more source

PS1-2 First report of cohort 3 and mature survival data from the U31402-A-U102 study of HER3-DXd in EGFR-mutated NSCLC [PDF]

, 2023
Hidetoshi Hayashi, Helena A. Yu, Christina S. Baik, Dong‐Wan Kim, Melissa L. Johnson, Makoto Nishio, James Chih‐Hsin Yang, Wu‐Chou Su, Kathryn A. Gold, Marianna Koczywas, Egbert F. Smit, Conor Steuer, Enriqueta Felip, Haruyasu Murakami, Sang‐We Kim, Ben Kim, Xin Su, Yoshimi Tanaka, Pang‐Dian Fan, F. Cantero   +19 more
openalex   +1 more source

Immunohistochemical Assessment of HER3 Expression in Odontogenic Cysts

, 2015
Marieh Honarmand, Shirin Saravani, Nazanin Kamyab, Mehdi Jahantigh, Molouk Torabi Parizi   +4 more
openalex   +1 more source

Development of Effective Therapeutics Targeting HER3 for Cancer Treatment [PDF]

, 2019
Xiaolong Liu, Shuang Liu, Hui Lyu, Adam I. Riker, Yamin Zhang, Bolin Liu   +5 more
openalex   +1 more source

Supplementary Data from Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells

, 2023
Young‐Kwang Yoon, Hwang‐Phill Kim, Sae‐Won Han, Hyung-Seok Hur, Do Youn Oh, Seock‐Ah Im, Yung‐Jue Bang, Tae‐You Kim   +7 more
openalex   +1 more source

An heregulin-EGFR-HER3 autocrine signaling axis can mediate acquired lapatinib resistance in HER2+ breast cancer models [PDF]

, 2013
Wenle Xia, Emanual Petricoin, Sumin Zhao, Lei-Hua Liu, Takuya Osada, Qing Cheng, Julia Wulfkuhle, William R. Gwin, Xiaoyi Yang, Rosa I. Gallagher, Sarah Bacus, H. Kim Lyerly, Neil L. Spector   +12 more
openalex   +1 more source